Two Sigma Securities, LLC Iterum Therapeutics PLC Transaction History

Two Sigma Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.31 - $0.45 $25,625 - $37,198	-82,664 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.39 - $0.74 $32,238 - $61,171	82,664 New	82,664 $32,000
Q2 2021 Aug 16, 2021	SELL	$0.97 - $2.39 $34,054 - $83,908	-35,108 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.97 - $2.73 $34,054 - $95,844	35,108 New	35,108 $50,000

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $16.8M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.